# Intergroup Corp: financial statements, quarterly

INTG · Nasdaq · CIK 69422 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/intg.md) · [Financials](/companies/intg/financials.md) · [Filings](/companies/intg/filings.md) · [Insiders](/companies/intg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/intg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.5](/filings/0001493152-24-045051.md) | [14.3](/filings/0001493152-25-006758.md) | [14.9](/filings/0001641172-25-010724.md) | [13.4 d](/filings/0001493152-25-016154.md) | [16.9](/filings/0001493152-25-021858.md) | [14.4](/filings/0001493152-26-006429.md) | [16.8](/filings/0001493152-26-022173.md) | [16.2 d](/filings/0001493152-26-044490.md) | [17.9](/filings/0001493152-25-021858.md) | [17.3](/filings/0001493152-26-006429.md) | [20.4](/filings/0001493152-26-022173.md) | [18.4 d](/filings/0001493152-26-044490.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [1.6](/filings/0001493152-24-045051.md) | [(1.3)](/filings/0001493152-25-006758.md) | [0.7](/filings/0001641172-25-010724.md) | [0.5 d](/filings/0001493152-25-016154.md) | [3.1](/filings/0001493152-25-021858.md) | [0.9](/filings/0001493152-26-006429.md) | [2.4](/filings/0001493152-26-022173.md) | [1.3 d](/filings/0001493152-26-044490.md) | [2.7](/filings/0001493152-25-021858.md) | [2.0](/filings/0001493152-26-006429.md) | [4.3](/filings/0001493152-26-022173.md) | [2.9 d](/filings/0001493152-26-044490.md) |
| Income tax | $m | [(0.0)](/filings/0001493152-24-045051.md) | [0.1](/filings/0001493152-25-006758.md) | [(0.3)](/filings/0001641172-25-010724.md) | [0.1 d](/filings/0001493152-25-016154.md) | [0.4](/filings/0001493152-25-021858.md) | [0.1](/filings/0001493152-26-006429.md) | [(0.0)](/filings/0001493152-26-022173.md) | [0.1 d](/filings/0001493152-26-044490.md) | [0.5](/filings/0001493152-25-021858.md) | [1.1](/filings/0001493152-26-006429.md) | [0.3](/filings/0001493152-26-022173.md) | [0.5 d](/filings/0001493152-26-044490.md) |
| Net income | $m | [(1.2)](/filings/0001493152-24-045051.md) | [(1.5)](/filings/0001493152-25-006758.md) | [(3.2)](/filings/0001641172-25-010724.md) | [(3.9) d](/filings/0001493152-25-016154.md) | [(0.4)](/filings/0001493152-25-021858.md) | [(2.7)](/filings/0001493152-26-006429.md) | [(0.6)](/filings/0001493152-26-022173.md) | [(1.6) d](/filings/0001493152-26-044490.md) | [(0.5)](/filings/0001493152-25-021858.md) | [1.5](/filings/0001493152-26-006429.md) | [0.5](/filings/0001493152-26-022173.md) | [0.2 d](/filings/0001493152-26-044490.md) |
| Diluted EPS | $ per share | [(0.56)](/filings/0001493152-24-045051.md) | [(0.69)](/filings/0001493152-25-006758.md) | [(1.44)](/filings/0001641172-25-010724.md) | not reported | [(0.18)](/filings/0001493152-25-021858.md) | [(1.26)](/filings/0001493152-26-006429.md) | [(0.27)](/filings/0001493152-26-022173.md) | not reported | [(0.25)](/filings/0001493152-25-021858.md) | [0.71](/filings/0001493152-26-006429.md) | [0.21](/filings/0001493152-26-022173.md) | not reported |
| Basic EPS | $ per share | [(0.56)](/filings/0001493152-24-045051.md) | [(0.69)](/filings/0001493152-25-006758.md) | [(1.44)](/filings/0001641172-25-010724.md) | not reported | [(0.18)](/filings/0001493152-25-021858.md) | [(1.26)](/filings/0001493152-26-006429.md) | [(0.27)](/filings/0001493152-26-022173.md) | not reported | [(0.25)](/filings/0001493152-25-021858.md) | [0.71](/filings/0001493152-26-006429.md) | [0.21](/filings/0001493152-26-022173.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-28) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.7](/filings/0001493152-23-041160.md) | [9.4](/filings/0001493152-24-007070.md) | [7.8](/filings/0001493152-24-019168.md) | [4.3](/filings/0001493152-25-016154.md) | [5.6](/filings/0001493152-24-045051.md) | [10.4](/filings/0001493152-25-006758.md) | [0.0](/filings/0001493152-25-016154.md) | [5.1](/filings/0001493152-26-044490.md) | [5.0](/filings/0001493152-25-021858.md) | [6.6](/filings/0001493152-26-006429.md) | [9.3](/filings/0001493152-26-022173.md) | [6.4](/filings/0001493152-26-044490.md) |
| Total assets | $m | [120](/filings/0001493152-23-041160.md) | [124](/filings/0001493152-24-007070.md) | [119](/filings/0001493152-24-019168.md) | [108](/filings/0001493152-25-016154.md) | [109](/filings/0001493152-24-045051.md) | [111](/filings/0001493152-25-006758.md) | [103](/filings/0001641172-25-010724.md) | [104](/filings/0001493152-26-044490.md) | [103](/filings/0001493152-25-021858.md) | [101](/filings/0001493152-26-006429.md) | [104](/filings/0001493152-26-022173.md) | [105](/filings/0001493152-26-044490.md) |
| Total liabilities | $m | [216](/filings/0001493152-23-041160.md) | [222](/filings/0001493152-24-007070.md) | [220](/filings/0001493152-24-019168.md) | [214](/filings/0001493152-25-016154.md) | [217](/filings/0001493152-24-045051.md) | [222](/filings/0001493152-25-006758.md) | [215](/filings/0001641172-25-010724.md) | [218](/filings/0001493152-26-044490.md) | [218](/filings/0001493152-25-021858.md) | [216](/filings/0001493152-26-006429.md) | [217](/filings/0001493152-26-022173.md) | [219](/filings/0001493152-26-044490.md) |
| Long-term debt | $m | [220](/filings/0001493152-23-041160.md) | [227](/filings/0001493152-24-007070.md) | [225](/filings/0001493152-24-019168.md) | [226](/filings/0001493152-24-038852.md) | [218](/filings/0001493152-24-045051.md) | [227](/filings/0001493152-25-006758.md) | [241](/filings/0001641172-25-010724.md) | [241](/filings/0001493152-25-016154.md) | [238](/filings/0001493152-25-021858.md) | [233](/filings/0001493152-26-006429.md) | [231](/filings/0001493152-26-022173.md) | not reported |
| Shareholders' equity | $m | [(72.5)](/filings/0001493152-23-041160.md) | [(73.0)](/filings/0001493152-24-007070.md) | [(76.4)](/filings/0001493152-24-019168.md) | [(80.3)](/filings/0001493152-25-016154.md) | [(80.9)](/filings/0001493152-24-045051.md) | [(83.9)](/filings/0001493152-25-006758.md) | [(84.5)](/filings/0001641172-25-010724.md) | [(86.1)](/filings/0001493152-26-044490.md) | [(86.7)](/filings/0001493152-25-021858.md) | [(85.2)](/filings/0001493152-26-006429.md) | [(84.7)](/filings/0001493152-26-022173.md) | [(84.5)](/filings/0001493152-26-044490.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,901](/filings/0001493152-24-045051.md) | [(1,981) d](/filings/0001493152-25-006758.md) | [1,862 d](/filings/0001641172-25-010724.md) | [5,031 d](/filings/0001493152-25-016154.md) | [3,360](/filings/0001493152-25-021858.md) | [(781) d](/filings/0001493152-26-006429.md) | [(854) d](/filings/0001493152-26-022173.md) | [4,168 d](/filings/0001493152-26-044490.md) | [(296)](/filings/0001493152-25-021858.md) | [(23.0) d](/filings/0001493152-26-006429.md) | [2,989 d](/filings/0001493152-26-022173.md) | [780 d](/filings/0001493152-26-044490.md) |
| Capital expenditure | $k | [754](/filings/0001493152-24-045051.md) | [1,164 d](/filings/0001493152-25-006758.md) | [731 d](/filings/0001641172-25-010724.md) | [1,430 d](/filings/0001493152-25-016154.md) | [269](/filings/0001493152-25-021858.md) | [346 d](/filings/0001493152-26-006429.md) | [297 d](/filings/0001493152-26-022173.md) | [1,340 d](/filings/0001493152-26-044490.md) | [974](/filings/0001493152-25-021858.md) | [458 d](/filings/0001493152-26-006429.md) | [354 d](/filings/0001493152-26-022173.md) | [412 d](/filings/0001493152-26-044490.md) |
| Share repurchases | $k | [39.0](/filings/0001493152-24-045051.md) | [142 d](/filings/0001493152-25-006758.md) | [248 d](/filings/0001641172-25-010724.md) | [170 d](/filings/0001493152-25-016154.md) | [205](/filings/0001493152-25-021858.md) | [178 d](/filings/0001493152-26-006429.md) | [11.0 d](/filings/0001493152-26-022173.md) | [0.0 d](/filings/0001493152-26-044490.md) | [73.0](/filings/0001493152-25-021858.md) | [0.0 d](/filings/0001493152-26-006429.md) | [0.0 d](/filings/0001493152-26-022173.md) | [0.0 d](/filings/0001493152-26-044490.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,482](/filings/0001493152-23-041160.md) | [2,467](/filings/0001493152-24-007070.md) | [2,211](/filings/0001493152-24-019168.md) | [2,205](/filings/0001493152-24-045051.md) | [2,203](/filings/0001493152-25-006758.md) | [2,193](/filings/0001641172-25-010724.md) | [2,173](/filings/0001493152-25-021858.md) | [2,166](/filings/0001493152-26-006429.md) | [2,155](/filings/0001493152-26-022173.md) | [2,151](/filings/0001493152-25-021858.md) | [2,149](/filings/0001493152-26-006429.md) | [2,149](/filings/0001493152-26-022173.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,148,812 at 2026-09-28, from the cover of the [10-K filed 2026-09-28](/filings/0001493152-26-044490.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.